日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Proposed Mechanisms and Associations of COVID-19 with Cardiometabolic Risk Factors

COVID-19 与心血管代谢风险因素的可能机制及关联

Reddy, Koushik R; Faridi, Kamil F; Aggarwal, Monica; Tirumalai, Adithi A; Singh, Tamanna; Tejtel, Kristen S; Williams, Kim; Litwin, Sheldon E; Dastmalchi, Lily Nedda; White, Beth Ann; Barnard, Neal; Ornish, Dean; Batts, Travis; Ajene, George; Aspry, Karen; Kris Etherton, Penny; Hull, Sarah C; Freeman, Andrew M

Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial

替泽帕肽对射血分数保留型心力衰竭合并肥胖患者的循环超负荷和终末器官损伤的影响:SUMMIT试验的二次分析

Borlaug, Barry A; Zile, Michael R; Kramer, Christopher M; Baum, Seth J; Hurt, Karla; Litwin, Sheldon E; Murakami, Masahiro; Ou, Yang; Upadhyay, Navneet; Packer, Milton

Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity

替尔泽帕肽对射血分数保留型心力衰竭合并肥胖患者临床病程的影响

Zile, Michael R; Borlaug, Barry A; Kramer, Christopher M; Baum, Seth J; Litwin, Sheldon E; Menon, Venu; Ou, Yang; Weerakkody, Govinda J; Hurt, Karla C; Kanu, Chisom; Murakami, Masahiro; Packer, Milton

HFpEF-ABA score is a more useful enrichment tool than natriuretic peptides in heart failure with preserved ejection fraction

在射血分数保留型心力衰竭中,HFpEF-ABA评分比利钠肽更能有效地富集患者。

Borlaug, Barry A; Zile, Michael R; Kramer, Christopher M; Litwin, Sheldon E; Ye, Wenyu; Ou, Yang; Hurt, Karla; Murakami, Masahiro; Packer, Milton

Supercharging the Heart With Ketones in Heart Failure With Preserved Ejection Fraction

利用酮体增强射血分数保留型心力衰竭患者的心脏功能

Reddy, Yogesh N V; Litwin, Sheldon E

Refining Atrial Shunt Therapy for Heart Failure With Preserved Ejection Fraction: Lessons From Pivotal Randomized Trials and Emerging Directions

改进射血分数保留型心力衰竭的心房分流治疗:来自关键随机试验的经验教训和新兴方向

Gyberg, Dylan J; Komtebedde, Jan; Mylavarapu, Uma; Litwin, Sheldon E; Leon, Martin B; Cutlip, Donald E; Solomon, Scott D; Starling, Randall C; Cikes, Maja; Borlaug, Barry A; Kaye, David M; HASENFUß, Gerd; Shah, Sanjiv J

Epicardial Adipose Tissue, Functional Status, and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction

射血分数保留型心力衰竭患者的心外膜脂肪组织、功能状态和有创血流动力学

Crum, Yoran; van Veldhuisen, Dirk J; Shah, Sanjiv J; Mylavarapu, Uma; Hu, Mo; Komtebedde, Jan; Lobeek, Michelle; Hoendermis, Elke S; Litwin, Sheldon E; Solomon, Scott D; Cutlip, Donald E; Leon, Martin B; Kaye, David; Bruch, Leonhard; Seidler, Tim; Cikes, Maja; Mohan, Rajeev; Lilly, Scott; Collins, Nicholas; Emani, Sitaramesh; Chetcuti, Stanley; Bugger, Heiko; Kotlyar, Eugene; Reed, Grant W; Gordon, Robert; Gupta, Deepak K; Borlaug, Barry A; Gorter, Thomas M

Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial

心房分流治疗心力衰竭:随机 RELIEVE-HF 试验

Stone, Gregg W; Lindenfeld, JoAnn; Rodés-Cabau, Josep; Anker, Stefan D; Zile, Michael R; Kar, Saibal; Holcomb, Richard; Pfeiffer, Michael P; Bayes-Genis, Antoni; Bax, Jeroen J; Bank, Alan J; Costanzo, Maria Rosa; Verheye, Stefan; Roguin, Ariel; Filippatos, Gerasimos; Núñez, Julio; Lee, Elizabeth C; Laufer-Perl, Michal; Moravsky, Gil; Litwin, Sheldon E; Prihadi, Edgard; Gada, Hemal; Chung, Eugene S; Price, Matthew J; Thohan, Vinay; Schewel, Dimitry; Kumar, Sachin; Kische, Stephan; Shah, Kevin S; Donovan, Daniel J; Zhang, Yiran; Eigler, Neal L; Abraham, William T

Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial

心房分流装置对射血分数保留型心力衰竭患者心脏结构和功能的影响:REDUCE LAP-HF II 随机临床试验

Patel, Ravi B; Silvestry, Frank E; Komtebedde, Jan; Solomon, Scott D; Hasenfuß, Gerd; Litwin, Sheldon E; Borlaug, Barry A; Price, Matthew J; Kawash, Rami; Hummel, Scott L; Cutlip, Donald E; Leon, Martin B; van Veldhuisen, Dirk J; Rieth, Andreas J; McKenzie, Scott; Bugger, Heiko; Mazurek, Jeremy A; Kapadia, Samir R; Vanderheyden, Marc; Ky, Bonnie; Shah, Sanjiv J

A novel controlled metabolic accelerator for the treatment of obesity-related heart failure with preserved ejection fraction: Rationale and design of the Phase 2a HuMAIN trial

一种用于治疗射血分数保留型肥胖相关性心力衰竭的新型可控代谢加速器:HuMAIN IIa期试验的原理和设计

Kitzman, Dalane W; Lewis, Gregory D; Pandey, Ambarish; Borlaug, Barry A; Sauer, Andrew J; Litwin, Sheldon E; Sharma, Kavita; Jorkasky, Diane K; Khan, Shaharyar; Shah, Sanjiv J